Mainboard · BSE and NSEListed

Hexagon Nutrition Limited IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 10:51 am IST · Source: Basis of allotment dated Thu 11 Jun 2026

Bid dates
Fri 5 Jun 2026 to Tue 9 Jun 2026
Listing date
Fri 12 Jun 2026
Issue price
₹45 per share

Listed on BSE and NSE on Fri 12 Jun 2026.

Listing price ₹48

Opening price on BSE on the listing day (BSE daily price file for Fri 12 Jun 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹45 per share
Prospectus dated Tue 9 Jun 2026, page 2
Lot size
Not stated in the prospectus
Prospectus dated Tue 9 Jun 2026
Lot amount at the upper band
Not stated in the prospectus
Prospectus dated Tue 9 Jun 2026
Issue size at the upper band
₹138.87 crore
Fresh issue
None
Prospectus dated Tue 9 Jun 2026, page 1
Offer for sale
₹138.87 crore
Prospectus dated Tue 9 Jun 2026, page 115
Bid dates
Fri 5 Jun 2026 to Tue 9 Jun 2026
Prospectus dated Tue 9 Jun 2026, page 1
Listing date
Fri 12 Jun 2026
BSE daily price file for Fri 12 Jun 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Tue 9 Jun 2026
Risk factors
97
Prospectus dated Tue 9 Jun 2026, page 113

Timeline (IST)

  1. OpensFri 5 Jun 2026, 10:00 am IST confirmedProspectus dated Tue 9 Jun 2026, page 1
  2. ClosesTue 9 Jun 2026 confirmedProspectus dated Tue 9 Jun 2026, page 1
  3. UPI mandate cut-offNot stated in the prospectus Prospectus dated Tue 9 Jun 2026
  4. AllotmentWed 10 Jun 2026 by T+3 schedule
  5. Refund and unblockThu 11 Jun 2026 by T+3 schedule
  6. Shares to dematThu 11 Jun 2026 by T+3 schedule
  7. ListingFri 12 Jun 2026 confirmedBSE daily price file for Fri 12 Jun 2026

Company and promoters

As described in the prospectus

Our product portfolio addresses a broad spectrum of nutritional aspects such as fortification of foods, therapeutic nutrition, clinical nutrition and alleviation of malnutrition.

Prospectus dated Tue 9 Jun 2026, page 274

Promoters

  • 5 individual promoters

Prospectus dated Tue 9 Jun 2026, page 399

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group89.41%45.74%

Prospectus dated Tue 9 Jun 2026, page 165

Financials (restated)

ItemNine month period ended December 31, 2025Fiscal 2025Fiscal 2024Fiscal 2023
Revenue from operations₹267.59 crore₹324.93 crore₹297.73 crore₹278.50 crore
Profit after tax₹27.03 crore₹24.38 crore₹12.21 crore₹5.82 crore
Net worth₹220.94 crore₹194.18 crore₹175.87 crore₹163.08 crore
Total borrowingsNot stated in the prospectusNot stated in the prospectusNot stated in the prospectusNot stated in the prospectus

Prospectus dated Tue 9 Jun 2026, page 120

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Individual shareholderIndividual15,36,477Not stated in the prospectus
Individual shareholderIndividual2,41,88,993Not stated in the prospectus
Individual shareholderIndividual15,26,092Not stated in the prospectus
Individual shareholderIndividual36,08,142Not stated in the prospectus
Total offer for sale₹138.87 crore

Prospectus dated Tue 9 Jun 2026, page 115

Peer comparison (as in the Prospectus)

Name of the CompanyFace value (₹)Revenue from operations (₹ in Million)Basic EPS (₹)Diluted EPS (₹)P/E (based on Diluted EPS) (1)Return on net worth (%)NAV per Equity Share (₹)
Hexagon Nutrition Limited13,249.291.751.7525.7112.4615.91
Zydus Wellness Limited*227,809.0010.9010.9046.226.12178.26
Nestlé India Limited^1202,015.6016.6316.6388.8677.9121.35

Reproduced from the Prospectus dated Tue 9 Jun 2026, page 176; InsightPier adds no figures

Risk factors

97 total
  1. Most revenue comes from the premix formulation segment (offer document page 34)
  2. A few customers account for a large share of revenue (offer document page 36)
  3. Rebuilding part of the Nashik facility may disrupt production (offer document page 39)
  4. Indian law may limit the company's ability to raise foreign capital (offer document page 113)
  5. Shareholder rights under Indian law may be narrower than elsewhere (offer document page 113)

All 97 risk factors, pages 34 to 114

Offer document

Allotment and bids

Registrar to the issue: KFin Technologies Limited.

Allotment status was expected on the registrar's site from Wed 10 Jun 2026 and is not yet confirmed. Pick "Hexagon Nutrition Limited" from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Retail Individual Investors1,08,00,89729,30,70,96927.13×
Non-Institutional Investors - More than ₹0.20 million Up to ₹1.00 million15,42,98518,35,45,604118.95×
Non-Institutional Investors - Above ₹1.00 million30,85,97156,84,60,970184.21×
Qualified Institutional Bidders (excluding Anchors Investors)61,72,15511,85,59,32219.21×
Anchor Investors92,57,6961,15,55,7811.25×
Total2,16,02,0081,16,36,36,86553.87×

Total: Excluding anchor investors

Basis of allotment dated Thu 11 Jun 2026, page 2

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts